» Articles » PMID: 22184186

Origins and Perspectives of Schizophrenia Research

Overview
Date 2011 Dec 21
PMID 22184186
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia is a complex psychiatric disorder with a heterogeneous clinical phenotype. Ancient paradigms focused on clinical experiences and hypotheses mostly without validated measurements but in the modern neuroscientific era the trend has turned oppositely; although an expanding body of evidence is available in association with the neurobiological background of schizophrenia, it seems that development of phenotypic description has been missing from the focus. However, now it is clear that a relevant and sophisticated diagnostic system is also essential for the appropriate interpretation of comprehensive molecular studies. Besides a brief review of most important data on schizophrenia research, the authors call attention to a complex diagnostic system (Composite Diagnostic Evaluation, CODE) which can be a valuable clinical partner of currently accepted models of schizophrenia, such as the neurodevelopmental hypothesis.

Citing Articles

Neurobiological effects of gallic acid: current perspectives.

Bhuia M, Rahaman M, Islam T, Bappi M, Sikder M, Hossain K Chin Med. 2023; 18(1):27.

PMID: 36918923 PMC: 10015939. DOI: 10.1186/s13020-023-00735-7.


Pharmacological screening of silibinin for antischizophrenic activity along with its acute toxicity evaluation in experimental animals.

Ain Q, Saleem U, Ahmad B, Khalid I Front Pharmacol. 2023; 14:1111915.

PMID: 36817163 PMC: 9936411. DOI: 10.3389/fphar.2023.1111915.


Targeting oxidative stress, acetylcholinesterase, proinflammatory cytokine, dopamine and GABA by eucalyptus oil (Eucalyptus globulus) to alleviate ketamine-induced psychosis in rats.

Yadav M, Jindal D, Parle M, Kumar A, Dhingra S Inflammopharmacology. 2018; 27(2):301-311.

PMID: 29464495 DOI: 10.1007/s10787-018-0455-3.


Correlation of DRD2 mRNA expression levels with deficit syndrome severity in chronic schizophrenia patients receiving clozapine treatment.

Liu L, Luo Y, Zhang G, Jin C, Zhou Z, Cheng Z Oncotarget. 2017; 8(49):86515-86526.

PMID: 29156812 PMC: 5689702. DOI: 10.18632/oncotarget.21230.


Protective effect of gallic acid in experimental model of ketamine-induced psychosis: possible behaviour, biochemical, neurochemical and cellular alterations.

Yadav M, Jindal D, Dhingra M, Kumar A, Parle M, Dhingra S Inflammopharmacology. 2017; 26(2):413-424.

PMID: 28577133 DOI: 10.1007/s10787-017-0366-8.